NSPR: InspireMD Company Sales Revenue

The vascular protection market is a rigid oligopoly characterized by aggressive pressure from industry behemoths. The consolidated sales dynamics of InspireMD, Inc. (NSPR) clearly illustrate the struggle for market share, where 0.01 reflects the latest metric level. Growth is driven by unique MicroNet stents that outperform competitors, supported by strict control over material safety and environmental production standards.

Revenue and Sales Volume: InspireMD (NSPR) for 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for InspireMD Inc. (NSPR)

- current price and projected stock value:

Share Price InspireMD|NSPR - Consensus Target

- market capitalization information:

Market Value InspireMD Corp|NSPR - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share InspireMD|NSPR - Book Capitalization|Market-to-Book Ratio inspiremd.com|NSPR - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

NSPR - Net Income|Expected Net Income InspireMD, Inc.|NSPR - P/E Multiple|Projected Price to Earnings Ratio InspireMD Inc|NSPR - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple InspireMD Inc.|NSPR - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) InspireMD|NSPR - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months inspiremd.com|NSPR - Earnings per share growth in current year|Net earnings per share change forecast for next year InspireMD, Inc.

- company sales and revenue statistics:

NSPR - Company Revenue|Company Future Sales Volume InspireMD, Inc.|NSPR - P/S Multiple|Market Cap to Future Revenue Ratio InspireMD Corp

Summary company analysis:NSPR InspireMD, Inc.

Stable cash flow determines the operational resilience of a business during periods of inflationary pressure. This metric measures average daily revenue against historical data to optimize risk hedging costs. For InspireMD, Inc. (NSPR), the automation of micro-stent production and its distribution network ensure high margins against fixed costs. Analyzing the trend of the company's commercial revenue allows for an assessment of the scaling efficiency of these technological advantages.

Key competitors